PSCC Innovation Forum 2025, les replays sont disponibles !

Revivez l'Innovation Forum 2025 !

Welcome address - Eric Vivier, PSCC 

Harnessing Natural Killer cells in cancer therapies - Olivier Demaria, R&D Director, Innate Pharma, France

IA and complex patient data for personnalized medicine - Vassili Soumelis, Owkin, France

Bioinformatics strategies to target cancer genomes for precision oncology - Fatima Al-Shahrour, Spanish National Cancer Research Center (CNIO), Spain

PSCC in action - 2024 in Achievements, 2025 in Focus, Benjamin Garel, PSCC

Accelerating innovation through cross-collaborations

• Expertise - Olivier Lavergne, E-Mirgency, Antoine Italiano, Gustave Roussy/Institut Bergonié, Frédéric Caroff, Hephaïstos Pharma,  Brian Dewitt, Prostperia, Frédéric Dhermain, Gustave Roussy

• Technology platforms - Albin Jeanne, Apmonia Therapeutics, Benjamin Besse, Gustave Roussy, Thomas Bancel, Hepta Medical, Eric Vibert and Elie Farha, BOPA (AP-HP, IMT)

• Campus Grand Parc site offer - Alain Vertes, OncoNex Remunity, Angélique Biancotto, Sanofi, Florent Ginhoux, Gustave Roussy

Spotlight on Innovation - PSCC’s portfolio highlights - Lucie Mondoulet and Patricia Zerr, PSCC

Startup pitch 1 - Léa Perles, Brenus Pharma

Startup pitch 2 - Kevin Carvalho, Deeplife

Startup pitch 3 - Sylvain Carlioz, Stimunity

Startup pitch 4 - Joana Cartocci, Robeauté

Inspiring talk (Christian Gavet) 

Award Pitch

Conclusion